Keywords: broad substrate specificity; isoleucine; lipomycin synthase a-Lipomycin is an acyclic polyene antibiotic isolated from Streptomyces aureofaciens Tü117 ( Figure 1a ). 1 Although cyclic polyene antibiotics such as nystatin and amphotericin generally show activity against fungi, a-lipomycin was reported to be a Grampositive bacteria-specific antibiotic. 1 The biosynthetic gene cluster of a-lipomycin was characterized by Bihlmaier et al. 2 They revealed the presence of four polyketide synthase (PKS) genes, lipPks1 ÀlipPks4, as well as genes that encode a nonribosomal peptide synthase, lipNrps, and a methyltransferase, lipMt, that together are responsible for the biosynthesis of b-lipomycin, the aglycone of a-lipomycin.
liter of HA medium in the absence of isoleucine. After 7 days, mycelia of each culture were extracted with acetone. After the extracts were concentrated, they were combined with their corresponding supernatants and acidified with HCl (pH ¼ B4). The resulting aqueous solutions were then extracted with ethyl acetate and concentrated. The crude extracts were analyzed by LC-MS. As shown in Figure 2 , we found that the culture grown in the presence of isoleucine exhibited a substantial amount of a compound that had a mass shift of þ 14 relative to a-lipomycin compared with the culture grown in the absence of isoleucine. To confirm the structure, we purified the analog by HPLC, obtaining 10 mg from 1 liter of the HA þ isoleucine culture, a yield comparable to that of a-lipomycin purified from 1 liter of HA culture (9 mg).
LC-MS analysis of a-lipomycin showed the presence of two sets of intense signals at m/z ¼ 588. 4 Figure 1B) . The theoretical exact mass of [M þ H] þ of 21-methyla-lipomycin is 602.33. The fragmented ions indicate that both a-lipomycin and the analog have the same sugar moiety, and that the þ 14 mass originates from a change in the backbone structure.
The orange-red color of a-lipomycin stems from the conjugated double-bond structure. The UV spectrum of a-lipomycin exhibited an absorbance at 448 nm with e 448 ¼ 29 800 (Supplementary Figure 2 , dotted line). As expected, the spectrum of the analog was nearly identical to that of a-lipomycin, l max ¼ 442 nm with e 442 ¼ 27 600 (Supplementary Figure 2 , solid line). These data indicate that the analog has a very similar p-electron conjugation system to a-lipomycin.
In order to elucidate the structure of the analog, we performed NMR analysis for both a-lipomycin and the analog. The 1 H NMR spectra of the analog and a-lipomycin were nearly identical except for the two regions: d H 0.88-1.02 p.p.m. and d H 1.54-1.83 p.p.m. (Table 1 and Supplementary Figures 3A, 7A, and 11) . These proton signals were assigned to be H20, H21 and H25 for a-lipomycin and H20, H21, H25 and the protons on the methyl group at C21 for the analog, respectively, by analysis of the 2D NMR spectra, DQF-COSY, TOCSY and HSQC (Supplementary Figures 4-6 and 8-10 ). It should be noted that the proton signal for H21 in the analog is a multiplet at d H 1.68 p.p.m., whereas the corresponding proton in a-lipomycin is a doublet at d H 0.99 p.p.m. In addition, a new proton signal appeared at 0.92 p.p.m. in the analog. On the basis of these NMR spectra, in conjunction with the MS and UV data, we determined the analog structure to be 21-methyl-a-lipomycin.
We also determined the MIC values for both compounds against B. subtilis and Escherichia coli, the latter a representative Gramnegative bacterium. The potencies were the same for the two compounds: MIC for B. subtilis ¼ 0.78 mg ml À1 and MIC for E. coli 4200 mg ml À1 . The results indicate that the activity is not affected by the structure of the starter substrate.
The avermectin family of polyketides is produced, in Streptomyces avermitilis, by a single PKS system whose loading didomain is capable of using isobutyryl-CoA or 2-methylbutyryl-CoA to start the synthesis. 4, 5 Because only a single lipomycin congener was isolated from S. aureofaciens Tü117, 1,2,6,7 it was assumed that the LipPks1 loading didomain was specific for isobutyryl-CoA.
Intrinsic substrate specificity of an enzyme can only be determined by in vitro kinetic analysis. Our previous kinetic studies of LipPks1 revealed that the k cat /K m values were comparable between isobutyrylCoA and 2-methylbutyryl-CoA, 3 suggesting that the lipomycin synthase could produce a methylated analog of a-lipomycin. In this work, we demonstrated the production of 21-methyl-a-lipomycin by increasing the intracellular concentration of 2-methylbutyryl-CoA. This highlights the importance of determining in vitro kinetic parameters for loading didomains of PKSs to expand the variety of identifiable drug candidates and thereby accelerate drug discovery.
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